$2.8M Bet On Repare Therapeutics

 

• The Trade: Repare Therapeutics Inc. RPTX 10% owner Mark Lampert acquired a total of 783,709 shares at an average price of $3.60. The insider spent around $2.82 million to buy those shares.
• What’s Happening: Repare Therapeutics posted a narrower-than-expected loss for its second quarter.
• What Repare Therapeutics Does: Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer.

https://www.benzinga.com/trading-ideas/long-ideas/23/11/35618770/2-8m-bet-on-repare-therapeutics-check-out-these-4-penny-stocks-insiders-are-aggressively